CN1760231A - Preparation method of degradable polymer material for punctal plug - Google Patents
Preparation method of degradable polymer material for punctal plug Download PDFInfo
- Publication number
- CN1760231A CN1760231A CN 200510030493 CN200510030493A CN1760231A CN 1760231 A CN1760231 A CN 1760231A CN 200510030493 CN200510030493 CN 200510030493 CN 200510030493 A CN200510030493 A CN 200510030493A CN 1760231 A CN1760231 A CN 1760231A
- Authority
- CN
- China
- Prior art keywords
- punctal plug
- polymerization
- polymer material
- degradable polymer
- glycolide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002861 polymer material Substances 0.000 title claims abstract description 25
- 229920006237 degradable polymer Polymers 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims description 6
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims abstract description 48
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 32
- 238000000034 method Methods 0.000 claims abstract description 23
- RKDVKSZUMVYZHH-UHFFFAOYSA-N 1,4-dioxane-2,5-dione Chemical group O=C1COC(=O)CO1 RKDVKSZUMVYZHH-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000004310 lactic acid Substances 0.000 claims abstract description 16
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 16
- JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical group CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 claims abstract description 16
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims abstract description 14
- 206010013774 Dry eye Diseases 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 9
- 229920001610 polycaprolactone Chemical group 0.000 claims abstract description 9
- 239000004632 polycaprolactone Chemical group 0.000 claims abstract description 9
- PAPBSGBWRJIAAV-UHFFFAOYSA-N ε-Caprolactone Chemical compound O=C1CCCCCO1 PAPBSGBWRJIAAV-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000178 monomer Substances 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 238000007151 ring opening polymerisation reaction Methods 0.000 claims abstract description 5
- 238000009833 condensation Methods 0.000 claims abstract description 4
- 238000006116 polymerization reaction Methods 0.000 claims description 25
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- 239000003054 catalyst Substances 0.000 claims description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 12
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- KSBAEPSJVUENNK-UHFFFAOYSA-L tin(ii) 2-ethylhexanoate Chemical compound [Sn+2].CCCCC(CC)C([O-])=O.CCCCC(CC)C([O-])=O KSBAEPSJVUENNK-UHFFFAOYSA-L 0.000 claims description 5
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 claims description 4
- 229910021626 Tin(II) chloride Inorganic materials 0.000 claims description 4
- 238000001125 extrusion Methods 0.000 claims description 4
- 239000000376 reactant Substances 0.000 claims description 4
- 235000011150 stannous chloride Nutrition 0.000 claims description 4
- 239000001119 stannous chloride Substances 0.000 claims description 4
- 239000011787 zinc oxide Substances 0.000 claims description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims description 3
- 229920001059 synthetic polymer Polymers 0.000 claims description 3
- 239000011135 tin Substances 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 229910001887 tin oxide Inorganic materials 0.000 claims description 2
- 229920002521 macromolecule Polymers 0.000 claims 1
- 230000009477 glass transition Effects 0.000 abstract description 15
- 241000083513 Punctum Species 0.000 abstract description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 abstract description 6
- 239000001569 carbon dioxide Substances 0.000 abstract description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 abstract description 3
- VUZPPFZMUPKLLV-UHFFFAOYSA-N methane;hydrate Chemical compound C.O VUZPPFZMUPKLLV-UHFFFAOYSA-N 0.000 abstract description 3
- 238000001356 surgical procedure Methods 0.000 abstract description 3
- 230000015556 catabolic process Effects 0.000 abstract description 2
- 238000006731 degradation reaction Methods 0.000 abstract description 2
- 238000000465 moulding Methods 0.000 abstract 1
- 238000002636 symptomatic treatment Methods 0.000 abstract 1
- JVTAAEKCZFNVCJ-REOHCLBHSA-N L-lactic acid Chemical compound C[C@H](O)C(O)=O JVTAAEKCZFNVCJ-REOHCLBHSA-N 0.000 description 16
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 15
- 239000000047 product Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- 238000011282 treatment Methods 0.000 description 8
- 239000000843 powder Substances 0.000 description 7
- JJTUDXZGHPGLLC-IMJSIDKUSA-N 4511-42-6 Chemical compound C[C@@H]1OC(=O)[C@H](C)OC1=O JJTUDXZGHPGLLC-IMJSIDKUSA-N 0.000 description 6
- 208000005156 Dehydration Diseases 0.000 description 3
- 230000018044 dehydration Effects 0.000 description 3
- 238000006297 dehydration reaction Methods 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 210000001508 eye Anatomy 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 206010006784 Burning sensation Diseases 0.000 description 1
- 208000032544 Cicatrix Diseases 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000002679 ablation Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 239000000607 artificial tear Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000005252 bulbus oculi Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000010102 embolization Effects 0.000 description 1
- 210000000744 eyelid Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000001354 painful effect Effects 0.000 description 1
- 238000000554 physical therapy Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 238000012643 polycondensation polymerization Methods 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000037387 scars Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
- Polyesters Or Polycarbonates (AREA)
Abstract
本发明属于高分子材料技术领域,具体涉及一种用于泪点栓的可降解高分子材料的制备方法,本发明以乳酸和乙醇酸或乳酸、乙醇酸和己内酯为单体用直接共缩聚法、或以丙交酯和乙交酯或丙交酯、乙交酯和聚己内酯开环聚合法合成玻璃化温度为32±1℃的可降解高分子材料,将得到的材料挤出成型,即得产品。通过本发明方法制得的泪点栓可用于治疗干眼症,因其玻璃化转变温度与人泪点处温度相适应,因手术过程温度高于或达到玻璃化转变温度,所以其性状呈橡胶状,很容易插入泪管,并且其直径变粗,从而使泪点栓不易脱落,另外,该泪点栓可降解,降解最终产物为二氧化碳和水,可以随泪液排出,于是可以免除以往干眼症治疗后期需取出泪点栓的手术。The invention belongs to the technical field of polymer materials, and in particular relates to a method for preparing a degradable polymer material used for punctum plugs. The invention uses lactic acid and glycolic acid or lactic acid, glycolic acid and caprolactone as monomers for direct co-condensation Synthesize a degradable polymer material with a glass transition temperature of 32±1°C by lactide and glycolide or lactide, glycolide and polycaprolactone ring-opening polymerization method, and extrude the obtained material Molding, that is, the product. The punctal plug prepared by the method of the present invention can be used to treat dry eye, because its glass transition temperature is compatible with the temperature of the human lacrimal point, and because the temperature during the operation is higher than or reaches the glass transition temperature, its properties are rubbery. shape, it is easy to insert into the lacrimal duct, and its diameter becomes thicker, so that the punctal plug is not easy to fall off. In addition, the punctal plug can be degraded, and the final products of degradation are carbon dioxide and water, which can be discharged with tears, so that the previous dry eye can be avoided. Surgery to remove the punctal plug is required in the later stage of symptomatic treatment.
Description
技术领域technical field
本发明属于高分子材料技术领域,具体涉及一种用于泪点栓的可降解高分子材料的制备方法,具体地说涉及一种用于治疗干眼症的可降解泪点栓材料的合成及泪点栓的制备方法。The invention belongs to the technical field of polymer materials, and in particular relates to a method for preparing a degradable polymer material for punctal plugs, in particular to a synthesis and preparation of degradable punctal plug materials for treating dry eye. Preparation method of punctal plug.
背景技术Background technique
因任何原因造成眼球的泪液层结构异常或各层成分分泌不足均可引起干眼症的发生,干眼症患者受很多症状的困扰,轻者表现为眼部干燥、眼红、烧灼感、异物感或眼酸感等,重者出现角膜弥漫性上皮点状或片状染色。For any reason, the abnormal structure of the tear layer of the eyeball or the insufficient secretion of components in each layer can cause dry eye syndrome. Patients with dry eye syndrome are troubled by many symptoms. In mild cases, the symptoms are dry eyes, red eyes, burning sensation, and foreign body sensation. Or eye soreness, severe cases appear diffuse corneal epithelial punctate or flake staining.
目前干眼症的治疗方法也有很多,主要有:(1)消除诱因;(2)人工泪液;(3)物理疗法,如热敷、眼睑按摩等;(4)泪点或泪管栓塞术。消除诱因是干眼症治疗的首选措施,但对于顽固性的干眼症,泪管阻塞或泪点阻塞仍可能是目前最好的方法,使之保留自身的自然泪液。最初封闭泪点的方法是使用热性泪点烧灼,该方法简单而有效,但是会引起疤痕,而且有疼痛,同时不可逆转。后来人们使用激光封闭泪点,但是据长期随访观察,20%术后泪点重新开启,激光法较热性烧灼法的优点是不会出现泪点疤痕。At present, there are many treatments for dry eye syndrome, mainly including: (1) eliminating the cause; (2) artificial tears; (3) physical therapy, such as hot compress, eyelid massage, etc.; (4) punctum or lacrimal duct embolization. Elimination of triggers is the first choice for the treatment of dry eye, but for intractable dry eye, blocked tear ducts or puncta may still be the best method at present, allowing them to retain their own natural tears. The initial method of sealing the puncta with thermal punctal cautery is simple and effective, but scarring, painful and irreversible. Later, people used laser to seal the puncta, but according to long-term follow-up observations, 20% of the puncta reopened after surgery. The advantage of the laser method over thermal ablation is that there will be no punctal scars.
泪点栓塞是一种较新的泪点封闭技术,植入泪点栓后,其机械阻塞作用减少了泪液的排出。目前泪点栓的材料大致分为两类,一类是不可降解的合成高分子材料,如硅胶、聚乙烯、氰基丙烯酸酯等,这类泪点栓的作用是永久型的,但在需要时可随时取出,最常用的是硅胶泪点栓,由于硅胶材料的弹性特征和设计特点,在泪流少时,起完全阻止作用,在泪流多时,在泪液的冲击下,能部分流通,通过动力系统的自动调节,重新建立泪液的平衡,从而大大增加了角膜表面湿润度。另一类泪点栓是以胶原等天然高分子材料为代表的自溶型泪点栓,该类泪点栓在植入泪点后一周内会自身溶解,可以作为泪点栓的暂时型的试用品,如置入后,症状或体征改善,就可以置入永久型泪点栓。Punctal plugging is a newer punctal closure technique in which the mechanical blocking action of a punctal plug reduces tear drainage. At present, the materials of punctal plugs can be roughly divided into two categories, one is non-degradable synthetic polymer materials, such as silica gel, polyethylene, cyanoacrylate, etc. It can be taken out at any time. The most commonly used is the silicone punctal plug. Due to the elastic characteristics and design characteristics of the silicone material, it can completely prevent the tear flow when there is little tear flow. The automatic adjustment of the power system re-establishes the balance of tears, thereby greatly increasing the corneal surface moisture. Another type of punctal plug is self-dissolving punctal plug represented by natural polymer materials such as collagen. This type of punctal plug will dissolve by itself within a week after implantation, and can be used as a temporary type of punctal plug. After the trial product is inserted, if the symptoms or signs improve, a permanent punctal plug can be inserted.
发明内容Contents of the invention
本发明的目的在于提出一种用于泪点栓的可降解高分子材料的制备方法。The purpose of the present invention is to propose a method for preparing a degradable polymer material used for punctal plugs.
本发明提出的用于泪点栓的可降解高分子材料的制备方法,以乳酸和乙醇酸或乳酸、乙醇酸和己内酯为单体用直接共缩聚法、或以丙交酯和乙交酯或丙交酯、乙交酯和聚己内酯开环聚合法合成玻璃化温度为32±1℃的可降解高分子材料,将得到的材料挤出成型,即得产品,聚合条件是:The preparation method of the degradable polymer material used for the punctal plug proposed by the present invention uses lactic acid and glycolic acid or lactic acid, glycolic acid and caprolactone as monomers with direct co-condensation polymerization, or with lactide and glycolide Or lactide, glycolide and polycaprolactone ring-opening polymerization method to synthesize a degradable polymer material with a glass transition temperature of 32±1°C, and extruding the obtained material to obtain the product. The polymerization conditions are:
(1)直接共缩聚法:乳酸和乙醇酸或乳酸、乙醇酸和己内酯的聚合,将单体除水后在催化剂存在下直接聚合,聚合温度150-180℃,时间12-18小时,压力50-70Pa,聚合结束后加入溶剂溶解,然后加入沉淀剂将聚合物沉淀,提纯产物,真空干燥,得到白色粉末状可降解高分子材料,反应物组成的摩尔比为;(1) Direct co-condensation method: polymerization of lactic acid and glycolic acid or lactic acid, glycolic acid and caprolactone, direct polymerization in the presence of a catalyst after removing water from the monomer, polymerization temperature 150-180 ° C, time 12-18 hours, pressure 50-70Pa, after the polymerization is completed, add a solvent to dissolve, then add a precipitant to precipitate the polymer, purify the product, and dry it in vacuum to obtain a white powdery degradable polymer material. The molar ratio of the reactants is:
乳酸∶乙醇酸的摩尔比为3∶7~7∶3;Lactic acid: the molar ratio of glycolic acid is 3: 7~7: 3;
乳酸∶乙醇酸∶己内酯的摩尔比为3.92∶5.88∶2~4.8∶3.2∶2;Lactic acid: glycolic acid: the molar ratio of caprolactone is 3.92: 5.88: 2~4.8: 3.2: 2;
(2)开环聚合法:丙交酯和乙交酯或丙交酯、乙交酯和聚己内酯的聚合,在催化剂存在下熔融聚合,聚合温度150-180℃,时间12-18小时,压力50-70Pa,聚合结束后加入溶剂溶解,然后加入沉淀剂沉淀,提纯产物,真空干燥,得到白色粉末状可降解高分子材料,反应物组成的摩尔比为;(2) Ring-opening polymerization method: polymerization of lactide and glycolide or lactide, glycolide and polycaprolactone, melt polymerization in the presence of a catalyst, polymerization temperature 150-180 ° C, time 12-18 hours , the pressure is 50-70Pa, after the polymerization is completed, add a solvent to dissolve, then add a precipitant to precipitate, purify the product, and dry it in vacuum to obtain a white powdery degradable polymer material. The molar ratio of the reactants is:
丙交酯∶乙交酯的摩尔比为3∶7~7∶3;The molar ratio of lactide:glycolide is 3:7~7:3;
丙交酯∶乙交酯∶聚己内酯摩尔比为3.92∶5.88∶2~4.8∶3.2∶2。The molar ratio of lactide:glycolide:polycaprolactone is 3.92:5.88:2˜4.8:3.2:2.
本发明中,乳酸与乙醇酸的摩尔比为4∶6~6∶4。In the present invention, the molar ratio of lactic acid to glycolic acid is 4:6˜6:4.
本发明中,丙交酯与乙交酯的摩尔比为4∶6~6∶4。In the present invention, the molar ratio of lactide to glycolide is 4:6˜6:4.
本发明中,所述催化剂是辛酸亚锡、氯化亚锡、锡或氧化锌等中的一种,催化剂加入量为单体总量的0.4-0.8%。In the present invention, the catalyst is one of stannous octoate, stannous chloride, tin or zinc oxide, etc., and the added amount of the catalyst is 0.4-0.8% of the total amount of monomers.
本发明中,聚合结束后加入的溶剂是四氢呋喃、氯仿或N,N-二甲基甲酰胺等中的一种。In the present invention, the solvent added after the polymerization is one of tetrahydrofuran, chloroform or N,N-dimethylformamide and the like.
本发明中,聚合结束后加入的沉淀剂是甲醇或乙醇等中的一种。In the present invention, the precipitating agent added after the polymerization is one of methanol or ethanol.
本发明中,将得到的材料熔融挤出,挤出温度是180-230℃。In the present invention, the obtained material is melt-extruded, and the extrusion temperature is 180-230°C.
本发明中,挤出成型加工成直径0.4-0.6mm,长度为8-10mm的圆柱状泪点栓。In the present invention, extrusion molding is processed into a cylindrical punctal plug with a diameter of 0.4-0.6 mm and a length of 8-10 mm.
本发明中制备得到的可降解合成高分子材料泪点栓在干眼症中的应用。由本发明方法制备得到的泪点栓,可通过挤出成型加工成直径为0.4~0.6mm,长度为9±1mm的圆柱状泪点栓(见图1)。由本发明制备得到的泪点栓可降解,植入泪点一定时间后,随着干眼症的治愈,泪点栓可自行降解,其直径变粗为1mm,长度为2mm的圆柱状(见图2),降解产物为二氧化碳和水,对人体无害,可随泪液排出,避免了二次手术,并且其玻璃化转变温度为32±1℃,手术容易。The application of the degradable synthetic polymer material punctal plug prepared in the present invention in dry eye syndrome. The punctal plug prepared by the method of the present invention can be processed into a cylindrical punctal plug with a diameter of 0.4-0.6 mm and a length of 9±1 mm by extrusion molding (see FIG. 1 ). The punctal plug prepared by the present invention is degradable. After being implanted into the punctum for a certain period of time, the punctal plug can be degraded automatically with the cure of dry eye. 2) The degradation products are carbon dioxide and water, which are harmless to the human body and can be discharged with tears, avoiding secondary operations, and the glass transition temperature is 32±1°C, making the operation easy.
本发明的优点:该泪点栓可用于治疗干眼症,在室温下,呈塑料特性,但因其玻璃化转变温度为32±1℃,与人泪点处温度相适应,所以在手术过程中,因温度高于或达到玻璃化转变温度,其性状呈橡胶状,易变形,很容易插入泪管,并且其直径变粗,从而使泪点栓不易脱落。另外,该泪点栓可生物降解,植入泪点一定时间后可降解,降解最终产物为二氧化碳和水,可以随泪液排出,于是可以免除以往干眼病治疗后期需取出泪点栓的手术。Advantages of the present invention: the punctum plug can be used to treat dry eye syndrome, and it is plastic at room temperature, but because its glass transition temperature is 32±1°C, which is compatible with the temperature of the human punctum, it can be used during the operation. Among them, because the temperature is higher than or reaches the glass transition temperature, its properties are rubbery, easy to deform, it is easy to insert into the lacrimal duct, and its diameter becomes thicker, so that the punctal plug is not easy to fall off. In addition, the punctal plug is biodegradable, and can be degraded after a certain period of time after being implanted in the punctum. The final products of degradation are carbon dioxide and water, which can be discharged with the tear fluid, thus eliminating the need for surgery to remove the punctal plug in the later stage of dry eye disease treatment.
附图说明Description of drawings
图1为植入泪点前泪点栓的形状。Figure 1 shows the shape of the punctal plug before implantation.
图2为植入泪点后一段时间泪点栓的形状。Figure 2 shows the shape of the punctum plug after a period of time after the puncta were implanted.
具体实施方式Detailed ways
实施例1Example 1
以D,L-乳酸为原料,加入等摩尔的乙醇酸,经除水处理后,加入催化剂辛酸亚锡(0.8%),在165℃和压力60Pa下,聚合14小时。反应结束后,加入四氢呋喃溶解、然后加入甲醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为31℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是180℃,制备出如图1所示的泪点栓。Using D, L-lactic acid as raw material, add equimolar glycolic acid, after water removal treatment, add catalyst stannous octoate (0.8%), polymerize at 165°C and pressure 60Pa for 14 hours. After the reaction, tetrahydrofuran was added to dissolve, then methanol was added to precipitate and purify the product, and vacuum-dried to obtain PLGA in the form of white powder with a glass transition temperature of about 31°C. The obtained white powdery PLGA was melt-extruded at a temperature of 180° C. to prepare a punctal plug as shown in FIG. 1 .
实施例2Example 2
以D,L-乳酸、乙醇酸为原料,D,L-乳酸、乙醇酸摩尔比为40∶60,经除水处理后,加入催化剂氯化亚锡(0.5%),在150℃和压力70Pa下,聚合18小时。反应结束后,加入N,N-二甲基甲酰胺溶解、然后加入乙醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为31.5℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是220℃,制备出如图1所示的泪点栓。Using D, L-lactic acid and glycolic acid as raw materials, the molar ratio of D, L-lactic acid and glycolic acid is 40:60, after dehydration treatment, adding catalyst stannous chloride (0.5%), at 150°C and pressure 70Pa Next, polymerize for 18 hours. After the reaction, add N,N-dimethylformamide to dissolve, then add ethanol to precipitate and purify the product, and vacuum dry to obtain PLGA in the form of white powder with a glass transition temperature of about 31.5°C. The obtained white powdery PLGA was melt-extruded at a temperature of 220° C. to prepare a punctal plug as shown in FIG. 1 .
实施例3Example 3
以L-乳酸为原料,加入等摩尔的乙醇酸,经除水处理后,加入催化剂氧化锌(0.8%),在180℃和压力50Pa下,聚合14小时。反应结束后,加入氯仿溶解、然后加入甲醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为33℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是190℃,制备出如图1所示的泪点栓。Using L-lactic acid as raw material, adding equimolar glycolic acid, after dehydration treatment, adding catalyst zinc oxide (0.8%), polymerizing at 180°C and pressure 50Pa for 14 hours. After the reaction was completed, chloroform was added to dissolve, then methanol was added to precipitate and purify the product, and vacuum-dried to obtain PLGA in the form of white powder with a glass transition temperature of about 33°C. The obtained white powdery PLGA was melt-extruded at a temperature of 190° C. to prepare a punctal plug as shown in FIG. 1 .
实施例4Example 4
以L-乳酸、乙醇酸为原料,L-乳酸、乙醇酸的摩尔比为45∶55,经除水处理后,加入催化剂锡(0.5%),在165℃和压力60Pa下,聚合14小时。反应结束后,加入四氢呋喃溶解、然后加入乙醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为32℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是210℃,制备出如图1所示的泪点栓。Using L-lactic acid and glycolic acid as raw materials, the molar ratio of L-lactic acid and glycolic acid is 45:55, after dehydration treatment, add catalyst tin (0.5%), polymerize at 165°C and pressure 60Pa for 14 hours. After the reaction, tetrahydrofuran was added to dissolve, then ethanol was added to precipitate and purify the product, and vacuum-dried to obtain PLGA in the form of white powder with a glass transition temperature of about 32°C. The obtained white powdery PLGA was melt-extruded at a temperature of 210° C. to prepare a punctal plug as shown in FIG. 1 .
实施例5Example 5
以D,L-丙交酯、乙交酯为原料,D,L-丙交酯、乙交酯的摩尔比为65∶35,加入催化剂辛酸亚锡(0.8%),在170℃和压力60Pa下,熔融聚合16小时。反应结束后,加入溶剂四氢呋喃溶解、然后加入乙醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为32.5℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是180℃,制备出如图1所示的泪点栓。Using D, L-lactide and glycolide as raw materials, the molar ratio of D, L-lactide and glycolide is 65:35, adding catalyst stannous octoate (0.8%), at 170°C and pressure 60Pa , melt polymerization for 16 hours. After the reaction, the solvent tetrahydrofuran was added to dissolve, and then ethanol was added to precipitate and purify the product, and vacuum-dried to obtain PLGA in the form of white powder with a glass transition temperature of about 32.5°C. The obtained white powdery PLGA was melt-extruded at a temperature of 180° C. to prepare a punctal plug as shown in FIG. 1 .
实施例6Example 6
以L-丙交酯、乙交酯为原料,L-丙交酯、乙交酯的摩尔比为40∶60,加入催化剂氯化亚锡(0.5%),在170℃和压力65Pa下,熔融聚合12小时。反应结束后,加入N,N-二甲基甲酰胺溶解、然后加入甲醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为31℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是230℃,制备出如图1所示的泪点栓。Using L-lactide and glycolide as raw materials, the molar ratio of L-lactide and glycolide is 40:60, add catalyst stannous chloride (0.5%), melt at 170°C and pressure 65Pa Polymerized for 12 hours. After the reaction, add N,N-dimethylformamide to dissolve, then add methanol to precipitate and purify the product, and dry it in vacuum to obtain white powder PLGA with a glass transition temperature of about 31°C. The obtained white powdery PLGA was melt-extruded at a temperature of 230° C. to prepare a punctal plug as shown in FIG. 1 .
实施例7Example 7
以L-乳酸、乙醇酸、己内酯为原料,L-乳酸、乙醇酸、己内酯的摩尔比为3.92∶5.88∶2,经除水处理后,加入催化剂氧化锌(0.8%),在175℃和压力70Pa下,聚合12小时。反应结束后,加入N,N-二甲基甲酰胺溶解、然后加入甲醇沉淀提纯产物,真空干燥得到白色粉末状共聚物,其玻璃化转变温度约为32.2℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是190℃,制备出如图1所示的泪点栓。With L-lactic acid, glycolic acid, and caprolactone as raw materials, the molar ratio of L-lactic acid, glycolic acid, and caprolactone is 3.92:5.88:2. After water removal treatment, a catalyst zinc oxide (0.8%) is added. Polymerization was carried out for 12 hours at 175° C. and a pressure of 70 Pa. After the reaction, add N,N-dimethylformamide to dissolve, then add methanol to precipitate and purify the product, and vacuum dry to obtain a white powdery copolymer with a glass transition temperature of about 32.2°C. The obtained white powdery PLGA was melt-extruded at a temperature of 190° C. to prepare a punctal plug as shown in FIG. 1 .
实施例8Example 8
以L-丙交酯、乙交酯、聚己内酯为原料,L-丙交酯、乙交酯、聚己内酯的摩尔比为4.8∶3.2∶2,加入催化剂辛酸亚锡(0.8%),在170℃和压力65Pa下,熔融聚合12小时。反应结束后,加入四氢呋喃溶解、然后加入沉淀剂乙醇沉淀提纯产物,真空干燥得到白色粉末状PLGA,其玻璃化转变温度约为31℃。将得到的白色粉末状PLGA熔融挤出,挤出温度是230℃,制备出如图1所示的泪点栓。With L-lactide, glycolide, polycaprolactone as raw materials, the molar ratio of L-lactide, glycolide, polycaprolactone is 4.8: 3.2: 2, add catalyst stannous octoate (0.8% ), at 170°C and a pressure of 65Pa, melt polymerization for 12 hours. After the reaction, tetrahydrofuran was added to dissolve, and then a precipitant was added to ethanol to precipitate and purify the product, and vacuum-dried to obtain a white powder PLGA with a glass transition temperature of about 31°C. The obtained white powdery PLGA was melt-extruded at a temperature of 230° C. to prepare a punctal plug as shown in FIG. 1 .
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510030493 CN1760231A (en) | 2005-10-13 | 2005-10-13 | Preparation method of degradable polymer material for punctal plug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510030493 CN1760231A (en) | 2005-10-13 | 2005-10-13 | Preparation method of degradable polymer material for punctal plug |
Publications (1)
Publication Number | Publication Date |
---|---|
CN1760231A true CN1760231A (en) | 2006-04-19 |
Family
ID=36706474
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510030493 Pending CN1760231A (en) | 2005-10-13 | 2005-10-13 | Preparation method of degradable polymer material for punctal plug |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1760231A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100413547C (en) * | 2006-08-30 | 2008-08-27 | 中国人民解放军军事医学科学院卫生装备研究所 | Lacrimal duct plug and its preparing process and use |
CN102018995A (en) * | 2010-12-09 | 2011-04-20 | 何伟 | Biodegradable lacrimal duct embolus and preparation method thereof |
CN102675858A (en) * | 2012-05-22 | 2012-09-19 | 同济大学 | Method for preparing degradable tear duct embolisms having shape memory function |
CN104984411A (en) * | 2015-07-17 | 2015-10-21 | 厦门浩益视生物科技有限公司 | Smart plug and preparation method thereof |
CN106667656A (en) * | 2016-06-30 | 2017-05-17 | 广州聚明生物科技有限公司 | Biodegradable lacrimal passage suppository and preparation method and application thereof |
-
2005
- 2005-10-13 CN CN 200510030493 patent/CN1760231A/en active Pending
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100413547C (en) * | 2006-08-30 | 2008-08-27 | 中国人民解放军军事医学科学院卫生装备研究所 | Lacrimal duct plug and its preparing process and use |
CN102018995A (en) * | 2010-12-09 | 2011-04-20 | 何伟 | Biodegradable lacrimal duct embolus and preparation method thereof |
CN102018995B (en) * | 2010-12-09 | 2013-08-21 | 何伟 | Biodegradable lacrimal duct embolus and preparation method thereof |
CN102675858A (en) * | 2012-05-22 | 2012-09-19 | 同济大学 | Method for preparing degradable tear duct embolisms having shape memory function |
CN104984411A (en) * | 2015-07-17 | 2015-10-21 | 厦门浩益视生物科技有限公司 | Smart plug and preparation method thereof |
CN106667656A (en) * | 2016-06-30 | 2017-05-17 | 广州聚明生物科技有限公司 | Biodegradable lacrimal passage suppository and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8163714B2 (en) | Injectable crosslinked and uncrosslinked alginates and the use thereof in medicine and in cosmetic surgery | |
AU2007240613B2 (en) | Polymeric compositions and methods of making and using thereof | |
DE69628783T2 (en) | Hydrogel-forming, self-solvating, absorbable polyester copolymers and methods for their use | |
KR101784863B1 (en) | Preparation Method of High Functional Suture coated with Hyaluronate and High Functional Suture Prepared Thereof | |
KR101649792B1 (en) | Polymer Foam Composition for Noncompression Hemostasis, Method Of Producing Polymer for Noncompression Hemostasis Foam Using The Same, And Polymer Foam for Packing Noncompression Hemostasis Therefrom | |
US8747870B2 (en) | Polymeric compositions and methods of making and using thereof | |
CN102675858A (en) | Method for preparing degradable tear duct embolisms having shape memory function | |
JP2018531123A6 (en) | Method for producing high-functional suture coated with hyaluronate and high-functional suture produced thereby | |
US20220362438A1 (en) | Derivatized or Rapidly Polymerizing Collagen Compositions for Tissue Augmentation Containing Nonresorbable or Slowly Resorbable Polymers | |
CN110038161A (en) | A kind of novel transparent matter acid flow-gel and its preparation method and application | |
CN1760231A (en) | Preparation method of degradable polymer material for punctal plug | |
CN103254595A (en) | Preparation method of degradable lacrimal passage bracket with shape memory function | |
JP2010540003A (en) | Resorbable barrier micromembrane for reducing healing scar tissue | |
CN103041454A (en) | Composite material for making degradable ureteral stent and application thereof | |
KR20200033487A (en) | A functional suture thread and a preparation method thereof | |
KR102580370B1 (en) | Adhesion barrier containing natural-polymer with biocompatibility and DNA fragment mixture, and process for producing the same | |
JP4378442B2 (en) | Anti-adhesion material | |
Shi et al. | Poly (propylene fumarate) | |
CN101618045A (en) | Anti-adhesion gel containing polyhydroxyalkanoate | |
WO2017171706A1 (en) | Amniotic or placental preparation and device for ophthalmic use as a dressing to enhance healing | |
JP4854299B2 (en) | Anti-adhesive material | |
US20160220485A1 (en) | Amniotic or placental preparation and device for ophthalmic use as a dressing to enhance healing | |
KR101005287B1 (en) | Scleral band-winning band and its manufacturing method | |
Sawhney et al. | Polymer synthesis | |
CN102631713A (en) | Degradable postoperative anti-adhesive membrane and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |